Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07122479 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prevention of Hospital Acquired Deconditioning in Hospitalized Acute Leukemia Patients

StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study completion date changed from estimate of Aug 2025 to Jul 17, 2026 Trial completed · Final enrollment: 21 participants (planned 50) · Eligibility criteria expanded, about 9 words Show 3 more changesShow less
    • Trial completed
    • Final enrollment: 21 participants (planned 50)
    • Eligibility criteria expanded, about 9 words
  2. Study description expanded, about 3 wordsv2 See this version in full on ClinicalTrials.gov ↗
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Northwell Health
133 trials monitored
See 10 trials at risk
Leukemia
2,566 trials monitored
See 143 trials at risk
This study aims to decrease the incidence of hospital acquired deconditioning (HAD) and to help standardize daily physical exercise monitoring in acute leukemia patients with anticipated prolonged duration of hospital stay. The investigators hypothesize that implementing a patient-reported adherence log of their recommended standard daily set of exercises will help reduce proportion of hospital acquired deconditioning in acute leukemia patients. The investigators also hypothesize that less adherent patients will have more inpatient hospital related events and decreased health related quality of life.
Trial Details
NCT Number NCT07122479
Lead Sponsor Northwell Health
Conditions Acute Leukemia
Enrollment 21 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov